SwePub
Sök i LIBRIS databas

  Extended search

(WFRF:(Patel Manesh R)) conttype:(refereed)
 

Search: (WFRF:(Patel Manesh R)) conttype:(refereed) > Comparison of an In...

  • Douglas, Pamela S (author)

Comparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery Disease: The PRECISE Randomized Clinical Trial.

  • Article/chapterEnglish2023

Publisher, publication year, extent ...

  • 2023

Numbers

  • LIBRIS-ID:oai:gup.ub.gu.se/328331
  • https://gup.ub.gu.se/publication/328331URI
  • https://doi.org/10.1001/jamacardio.2023.2595DOI

Supplementary language notes

  • Language:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Trials showing equivalent or better outcomes with initial evaluation using coronary computed tomography angiography (cCTA) compared with stress testing in patients with stable chest pain have informed guidelines but raise questions about overtesting and excess catheterization.To test a modified initial cCTA strategy designed to improve clinical efficiency vs usual testing (UT).This was a pragmatic randomized clinical trial enrolling participants from December 3, 2018, to May 18, 2021, with a median of 11.8 months of follow-up. Patients from 65 North American and European sites with stable symptoms of suspected coronary artery disease (CAD) and no prior testing were randomly assigned 1:1 to precision strategy (PS) or UT.PS incorporated the Prospective Multicenter Imaging Study for the Evaluation of Chest Pain (PROMISE) minimal risk score to quantitatively select minimal-risk participants for deferred testing, assigning all others to cCTA with selective CT-derived fractional flow reserve (FFR-CT). UT included site-selected stress testing or catheterization. Site clinicians determined subsequent care.Outcomes were clinical efficiency (invasive catheterization without obstructive CAD) and safety (death or nonfatal myocardial infarction [MI]) combined into a composite primary end point. Secondary end points included safety components of the primary outcome and medication use.A total of 2103 participants (mean [SD] age, 58.4 [11.5] years; 1056 male [50.2%]) were included in the study, and 422 [20.1%] were classified as minimal risk. The primary end point occurred in 44 of 1057 participants (4.2%) in the PS group and in 118 of 1046 participants (11.3%) in the UT group (hazard ratio [HR], 0.35; 95% CI, 0.25-0.50). Clinical efficiency was higher with PS, with lower rates of catheterization without obstructive disease (27 [2.6%]) vs UT participants (107 [10.2%]; HR, 0.24; 95% CI, 0.16-0.36). The safety composite of death/MI was similar (HR, 1.52; 95% CI, 0.73-3.15). Death occurred in 5 individuals (0.5%) in the PS group vs 7 (0.7%) in the UT group (HR, 0.71; 95% CI, 0.23-2.23), and nonfatal MI occurred in 13 individuals (1.2%) in the PS group vs 5 (0.5%) in the UT group (HR, 2.65; 95% CI, 0.96-7.36). Use of lipid-lowering (450 of 900 [50.0%] vs 365 of 873 [41.8%]) and antiplatelet (321 of 900 [35.7%] vs 237 of 873 [27.1%]) medications at 1 year was higher in the PS group compared with the UT group (both P < .001).An initial diagnostic approach to stable chest pain starting with quantitative risk stratification and deferred testing for minimal-risk patients and cCTA with selective FFR-CT in all others increased clinical efficiency relative to UT at 1 year. Additional randomized clinical trials are needed to verify these findings, including safety.ClinicalTrials.gov Identifier: NCT03702244.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Nanna, Michael G (author)
  • Kelsey, Michelle D (author)
  • Yow, Eric (author)
  • Mark, Daniel B (author)
  • Patel, Manesh R (author)
  • Rogers, Campbell (author)
  • Udelson, James E (author)
  • Fordyce, Christopher B (author)
  • Curzen, Nick (author)
  • Pontone, Gianluca (author)
  • Maurovich-Horvat, Pál (author)
  • De Bruyne, Bernard (author)
  • Greenwood, John P (author)
  • Marinescu, Victor (author)
  • Leipsic, Jonathon (author)
  • Stone, Gregg W (author)
  • Ben-Yehuda, Ori (author)
  • Berry, Colin (author)
  • Hogan, Shea E (author)
  • Redfors, BjörnGothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine(Swepub:gu)xredbj (author)
  • Ali, Ziad A (author)
  • Byrne, Robert A (author)
  • Kramer, Christopher M (author)
  • Yeh, Robert W (author)
  • Martinez, Beth (author)
  • Mullen, Sarah (author)
  • Huey, Whitney (author)
  • Anstrom, Kevin J (author)
  • Al-Khalidi, Hussein R (author)
  • Vemulapalli, Sreekanth (author)
  • Göteborgs universitetInstitutionen för medicin, avdelningen för molekylär och klinisk medicin (creator_code:org_t)
  • Göteborgs universitet
  • Gothenburg University

Related titles

  • In:JAMA cardiology2380-6591

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view